BIOMAT Database Logo BIOMAT Database Logo

[Clinical experiences with Des-Phe B1 insulins]. 1976

H Hasche, and B Willms

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D010649 Phenylalanine An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE. Endorphenyl,L-Phenylalanine,Phenylalanine, L-Isomer,L-Isomer Phenylalanine,Phenylalanine, L Isomer
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Hasche, and B Willms
[Clinical experiences with monocomponent insulins].
March 1975, Minerva medica,
H Hasche, and B Willms
Preparation and characterization of diphenylthiocarbamyl-insulin and des-gly A1-des phe B1-insulin (bovine).
April 1970, Biochemistry,
H Hasche, and B Willms
Clinical trial with porcine des-Phe B1 insulin. A comparative study with unmodified insulin on therapeutical efficacy, biological activity and immunogenicity.
September 1981, Diabete & metabolisme,
H Hasche, and B Willms
Chemical synthesis of [des(tetrapeptide B27--30), Tyr(NH2)26-B] and [des(pentapeptide B26--30), Phe(NH2)25-B] bovine insulins.
January 1979, International journal of peptide and protein research,
H Hasche, and B Willms
[Long-term treatment with Des-Phe-Insulin].
December 1982, Wiener klinische Wochenschrift,
H Hasche, and B Willms
Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.
July 1991, Biological chemistry Hoppe-Seyler,
H Hasche, and B Willms
Experiences with the lente insulins in diabetic children.
May 1959, The Illinois medical journal,
H Hasche, and B Willms
Clinical experience with intermediate insulins.
September 1955, Pennsylvania medical journal (1928),
H Hasche, and B Willms
Clinical experience with the new insulins.
January 1978, The Ulster medical journal,
H Hasche, and B Willms
[Treatment with Scandinavian insulins. Clinical report].
May 1982, Die Medizinische Welt,
Copied contents to your clipboard!